Integrated layer
PEPDIA-INT-076346
Unnamed peptide
HCKFWF
Primary-literature peptide layer
PEPDIA-PLP-001493
KKCH
KKCHFWPFPW
45 observations · 1 papers
Primary literaturePEPDIA-PLP-001871
Pis v 1
LQELYETASELPR
34 observations · 1 papers
Primary literaturePEPDIA-PLP-002822
Pis v 2.0101
TNGLSQTSQLAGR
34 observations · 1 papers
Primary literaturePEPDIA-PLP-000726
LFCA
FKCRRWQWRMKKLGAPSITCVRRAFGGGSSVDGKEDLIWKLLSKAQEKFGKNKSR
18 observations · 1 papers
Primary literaturePEPDIA-PLP-001878
C1
LQYPDDSDDE
17 observations · 1 papers
Primary literaturePEPDIA-PLP-002612
DFTavP1
RWLRGLLSGLLRRLLSGLLL
14 observations · 1 papers
Evidence inquiry layer
The in vitro HIV-1 infection model revealed 2.5-fold lower mean IC50 for bio-synthetic modified enfuvirtide 0.0453 μM [95% CI 0.0316–0.0650].
the standard had 0.0180 μM [95% CI 0.0090–0.0359].
Table 1: G54-LDL EC50/IC50 <0.5 µM (EMSA).
